The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C

Clinical Chemistry and Laboratory Medicine

Volumn 36, Issue 3, 1998, Pages 175-178

  Norlund, Lena ^a   Grubb, Anders ^a   Fex, Göran ^a   Leksell, Håkan ^b   Nilsson, Jan Erik ^b   Schenck, Henning ^b   Hultberg, Björn ^a  

^a LUND UNIVERSITY   (Sweden)

^b CENTRAL HOSPITAL   (Sweden)

Author keywords

Creatinine; Cystatin C; Healthy population; Homocysteine; Plasma; Renal function

Indexed keywords

CREATINE; CREATININE; CYSTATIN C; HOMOCYSTEINE;

ADULT; AGED; AGING; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN EXPERIMENT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; SEX DIFFERENCE;

GLOMERULUS;

EID: 0031922856     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1998.032     Document Type: Article

References (23)

1. Mudd SH, Levy HL and Skovby F. Disorders of transsulfuration. In: Scriver CG, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited disease. 6th ed. New York: McGraw-Hill Book Co., 1989:693-734.
2. Brattström L, Hardebo J, Hultberg B. Moderate homocysteinemia - a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 1984; 15:1012-6.
3. Boers GHJ, Smals AGH, Trijbels FJM, Fowler B, Bakkeren JAJM, Schoonderwaldt HC, et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985; 313:709-15.
4. Malinow MR, Kang SS, Taylor LM, Wong PWK, Coull B, Inahara T, et al. Prevalence of hyperhomocysteinemia in patients with peripheral arterial occlusive disease. Circulation 1989; 79:1180-9.
5. Clarke R, Leslie D, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324:1149-55.
6. Stampfer MJ, Malinow MR, Willet WC, Newcomer LM, Upson B, Ullman D, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. J Am Med Ass 1992; 268:877-81.
7. Boushey CJ, Beresford SAA, Omen GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Ass 1995; 274:1049-56.
8. Malinow MR. Plasma homocysteine and arterial occlusive diseases: a mini-review. Clin Chem 1995; 41:173-6.
9. Hultberg B, Andersson A, Sterner G. Plasma homocysteine in renal failure. Clin Nephrol 1993; 40:230-6.
10. Soria C, Chadefaux B, Coude M, Gaillard O, Kamoun P. Concentrations of total homocysteine in plasma in chronic renal failure. Clin Chem 1990; 36:2137-9.
11. Wilcken DEL, Gupta VJ. Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide. Eur J Clin Invest 1979; 9:301-7.
12. Andersson A, Brattström B, Israelsson B, lsaksson A, Hamfelt A, Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender and menopausal status. Eur J Clin Invest 1992; 22:79-87.
13. Brattström L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994; 236:633-41.
14. Berg B, Solberg HE, Nilsson J-E, Tryding N. Practical experience in the selection and preparation of reference individuals: empirical testing of the provisional Scandinavian recommendations. In: Gräsbäck R, Alström T, editors. Reference values in laboratory medicine. Chichester, UK: John Wiley & Sons Ltd., 1981; 55-64.
15. Kyhse-Andersson J, Schmidt C, Nordin G, Andersson B, Nilsson Ehle P, Lindström V, et al. Serum cystatin C, determined by a rapid automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994; 40:1921-6.
16. Tenstad O, Roald AB, Grubb A, Aukland K. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab 1996; 56:409-14.
17. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb A, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47:312-8.
18. Grubb A, Nilsson-Ehle P, Vinge E, Lindergård B. Serum cystatin C is, in contrast to serum creatinine, a muscle mass independent marker for GFR. Abstract no. B 258 in Proceedings of the XVI International Congress of Clinical Chemistry. London, UK, 8-12 Jul 1996. Martins SM, Halloran SP, editors. Cambridge: Piggot Printers Limited, 1996.
19. Andersson A, lsaksson A, Brattström L, Hultberg B. Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization. Clin Chem 1993; 39:1590-7.
20. Bäck S-E, Ljungberg B, Nilsson-Ehle I, Borgå O, Nilsson-Ehle P. Age dependence of renal function: clearance of iohexol and P-amino hippurate in healthy males. Scand J Clin Lab Invest 1989; 49:641-6.
21. Bostom A, Brosnan JT, Hall B, Nadeau MR, Selhub J. Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 1995; 116:59-62.
22. Guttormsen AB, Svarstad E, Ueland PM, Refsum H. Elimination of homocysteine from plasma in subjects with end stage renal failure [abstract]. Irish J Med Sci 1995; 164 Suppl 15:8-9.
23. Mudd SH, Poole JR. Labile methyl balances for normal humans on various dietary regimens. Metabolism 1975; 24:721-8.